X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (122) 122
humans (110) 110
hematology (88) 88
female (78) 78
male (77) 77
aged (69) 69
middle aged (66) 66
multiple myeloma (60) 60
oncology (56) 56
multiple myeloma - drug therapy (51) 51
adult (50) 50
bortezomib (43) 43
therapy (36) 36
survival (35) 35
prognosis (32) 32
stem-cell transplantation (32) 32
aged, 80 and over (30) 30
multiple myeloma - therapy (30) 30
multiple myeloma - pathology (29) 29
antineoplastic combined chemotherapy protocols - therapeutic use (28) 28
transplantation (28) 28
treatment outcome (28) 28
thalidomide (27) 27
abridged index medicus (25) 25
multiple myeloma - mortality (24) 24
hematology, oncology and palliative medicine (23) 23
transplantation, autologous (22) 22
care and treatment (21) 21
dexamethasone (21) 21
monoclonal gammopathy (18) 18
multiple myeloma - diagnosis (18) 18
risk factors (18) 18
dexamethasone - administration & dosage (17) 17
stem cells (17) 17
cancer (16) 16
multiple myeloma - genetics (16) 16
antineoplastic agents - therapeutic use (15) 15
chemotherapy (15) 15
diagnosis (15) 15
disease progression (15) 15
patients (15) 15
remission induction (15) 15
disease-free survival (14) 14
follow-up studies (14) 14
immunology (14) 14
lenalidomide (14) 14
melphalan (14) 14
recurrence (14) 14
stem cell transplantation (14) 14
survival rate (14) 14
thalidomide - administration & dosage (14) 14
thalidomide - analogs & derivatives (14) 14
multiple-myeloma (13) 13
progression (13) 13
amyloidosis (12) 12
autologous transplantation (12) 12
boronic acids - administration & dosage (12) 12
complete remission (12) 12
high-dose therapy (12) 12
minimal residual disease (12) 12
plus dexamethasone (12) 12
pyrazines - administration & dosage (12) 12
thalidomide - therapeutic use (12) 12
hematopoietic stem cell transplantation (11) 11
medicine, general & internal (11) 11
survival analysis (11) 11
antineoplastic combined chemotherapy protocols - adverse effects (10) 10
criteria (10) 10
myeloma (10) 10
prednisone (10) 10
bone-marrow (9) 9
development and progression (9) 9
kaplan-meier estimate (9) 9
randomized-trial (9) 9
undetermined significance (9) 9
analysis (8) 8
bone-marrow-transplantation (8) 8
boronic acids - therapeutic use (8) 8
carfilzomib (8) 8
clinical trials (8) 8
complete response (8) 8
elderly-patients (8) 8
health aspects (8) 8
induction (8) 8
leukemia (8) 8
melphalan - administration & dosage (8) 8
multiple myeloma - blood (8) 8
proteins (8) 8
pyrazines - therapeutic use (8) 8
research (8) 8
risk (8) 8
trial (8) 8
antineoplastic agents - administration & dosage (7) 7
autografts (7) 7
dexamethasone - therapeutic use (7) 7
disease (7) 7
drug therapy (7) 7
hematopoietic stem cells (7) 7
hemic and lymphatic diseases (7) 7
lenalidomide plus dexamethasone (7) 7
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2016, Volume 17, Issue 1, pp. 27 - 38
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 01/2015, Volume 372, Issue 2, pp. 142 - 152
Journal Article
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 08/2013, Volume 369, Issue 5, pp. 438 - 447
Journal Article
Journal Article
Journal Article
Journal Article
British Journal of Haematology, ISSN 0007-1048, 05/2017, Volume 177, Issue 3, pp. 404 - 413
Journal Article
British Journal of Haematology, ISSN 0007-1048, 08/2017, Volume 178, Issue 4, pp. 547 - 560
Journal Article
Gut, ISSN 0017-5749, 09/2016, Volume 65, Issue 9, pp. 1456 - 1462
Journal Article